COMP <GO>
BWMN vs PG // REVENUE GROWTH (YOY)
Bowman Consulting Group Ltd. (NASDAQ) VS. Procter & Gamble Company (NYSE) • 15-METRIC TALLY: BWMN 4
— PG 8
▲ REVENUE GROWTH (YOY) LEADER: BWMN
LAST: $42.86 (0.00%) • MKT CAP: $743.0M
revenue-growth
14.90%
LAST: $160.59 (+1.47%) • MKT CAP: $372.21B
revenue-growth
0.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BWMN VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BWMN | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 53.40% | 51.20% | +2.20 | BWMN | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 6.20% | 25.40% | -19.20 | PG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 33.7x | 16.2x | +17.50 | PG | /valuation <GO> |
| Free Cash Flow Yield | 4.50% | 3.77% | +0.73 | BWMN | /fcf-yield <GO> |
| Operating Margin | 4.00% | 24.30% | -20.30 | PG | /operating-margins <GO> |
| Net Profit Margin | 2.60% | 19.00% | -16.40 | PG | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 14.90% | 0.30% | +14.60 | BWMN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.65% | -2.65 | PG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.33 | 5.59 | -3.26 | PG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 71.9 | 60.3 | +11.60 | BWMN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.87 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 48.6x | 21.7x | +26.90 | PG | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $743.0M | $372.21B | -$371.47B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BWMN REV | PG REV | BWMN GROSS % | PG GROSS % | BWMN FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $490.0M | $84.28B | 53.4% | 51.2% | $33.4M | $14.04B |
| FY 2024 | $426.6M | $84.04B | 52.2% | 51.4% | $23.7M | $16.52B |
| FY 2023 | $346.3M | $82.01B | — | — | $11.7M | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BWMN // BETA —
PG // BETA 0.87